Document is current
Any future updates will be listed below
-
Authors
O’Donnell, Charles W.
Farelli, Jeremiah D. https://orcid.org/0000-0003-2742-2257
Belaghzal, Houda
Chen, Justin https://orcid.org/0000-0002-1661-4547
Beech, Lauren
Sullivan, James
Morrison-Smith, Chevaun
Siecinski, Stephen
Katz, Adam
Mildrum, Samuel
Gurnani, Mayur
Dhanania, Prachi
Webb, Caitlyn R.
Castello Coatti, Giuliana
Rumale, Pranjali
Costa, Daniel F. G.
Gibson, Marcus I. https://orcid.org/0000-0003-0788-5510
Wang, Yaoyu E.
Newman, Joseph V.
McCauley, Thomas G.
- License Information
-
More Information
Article History
Received: 15 November 2023
Accepted: 7 March 2025
First Online: 13 March 2025
Competing interests
: All authors were employees of Omega Therapeutics when the work was conducted. All authors were or currently are shareholders of Omega Therapeutics stock and/or options. T.G.M. is the former Chief Scientific Officer of Omega Therapeutics.
